Skip to main content
Clinical Trials/NCT05314842
NCT05314842
Unknown
Phase 3

Clinical and Radiographic Evaluation of Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol Among a Group of Egyptian Children: A Pilot Study.

Sarah Abdelbar Mahmoud0 sites40 target enrollmentApril 1, 2022

Overview

Phase
Phase 3
Intervention
Formocresol
Conditions
Caries
Sponsor
Sarah Abdelbar Mahmoud
Enrollment
40
Primary Endpoint
Soft-tissue pathology
Last Updated
4 years ago

Overview

Brief Summary

examine the results of pulpotomy in primary molars using premixed bioceramic MTA versus Formocresol. Clinical and radiographic success rates were used as outcomes.

Detailed Description

Primary outcome: Soft-tissue pathology * Post-treatment swelling will be assessed through visual examination by the operator, either intraorally or extra orally. * Sinus tract or fistula will be assessed through visual examination by the operator Secondary outcomes: 1. Pain to the percussion will be assessed by gentle tapping on the tooth with the end of a dental mirror 2. mobility will be assessed through the back of two mirrors 3. radiographic assessments:- for any radiolucency and pathologic root resorption (periapical or bifurcation) will be examined (present or not). clinical assessment on every recall visit during the 3-, 6-, and 12-month follow-up period. • These radiographic assessments will be performed as baseline data at the first visit following the operating procedure, as well as at 3, 6, and 12 months after the baseline.

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
May 1, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Sarah Abdelbar Mahmoud
Responsible Party
Sponsor Investigator
Principal Investigator

Sarah Abdelbar Mahmoud

principal investigator

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Medically fit and cooperative children.
  • Pediatric patients aged 4-6 years.
  • A deep carious lesion in vital primary molars.
  • Absence of clinical signs and symptoms of pulpal exposure.
  • Absence of radiographic signs and symptoms of people degeneration.
  • Positive parental informed consent.

Exclusion Criteria

  • Uncooperative children.
  • Medically compromised children.
  • Presence of clinical signs and symptoms of pulpal exposure.
  • Presence of radiographic signs and symptoms of pulp degeneration.
  • Physiologic root resorption more than one-third.

Arms & Interventions

control group

the group that have caries in primary molars and treat them with formocresol

Intervention: Formocresol

experimental group

the group that have caries in primary molars and treat them with premixed bioceramic MTA

Intervention: Premixed bioceramic MTA

Outcomes

Primary Outcomes

Soft-tissue pathology

Time Frame: at 1 year

Post-treatment swelling will be assessed through visual examination by the operator, either intraorally or extra orally. -Sinus tract or fistula will be assessed through visual examination by the operator. Binary (present or absent)

Secondary Outcomes

  • mobility(at 1 year)
  • radiographic indications of radiolucency and pathologic root resorption (periapical or bifurcation) will be examined (present or not).(at 1 year)
  • • Pain to the percussion(at 1 year)

Similar Trials